ReleaseWire

Just Published: "Global Thyroid Gland Disorder Treatment Market 2017-2021"

Fast Market Research announces the availability of the new TechNavio report, "Global Thyroid Gland Disorder Treatment Market 2017-2021", on their comprehensive research portal

Posted: Thursday, April 13, 2017 at 7:29 AM CDT

Boston, MA -- (SBWire) -- 04/13/2017 --The thyroid gland plays an important role in maintaining the functions of different organs in the body such as the heart, brain, liver, kidneys, and skin. It produces T4 and T3 hormones. The thyroid-stimulating hormone (TSH) determines the quantity of the T3 and T4 hormones production in the body. The hormones are produced and stored in the microscopic follicles of the thyroid gland. The levels of thyroid hormones are maintained with a good network of communication between the hypothalamus, pituitary gland, and thyroid gland (HPT). Slight changes in the HPT axis due to any disease, damage to the thyroid, or the use of certain medicines will lead to either low or excess production of thyroid hormones, leading to hyperthyroidism and hypothyroidism.

Technavio's analysts forecast the global thyroid gland disorder treatment market to grow at a CAGR of 3.24% during the period 2017-2021.

Get More Details on this Report and a Full Table of Contents at Global Thyroid Gland Disorder Treatment Market 2017-2021

Covered in this report
The report covers the present scenario and the growth prospects of the global thyroid gland disorder treatment market for 2017-2021. To calculate the market size, the report considers the global demand for thyroid gland disorder treatment.

The market is divided into the following segments based on geography:

-Americas
-APAC
-EMEA

Technavio's report, Global Oscilloscope Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

-AbbVie
-Pfizer
-Merck Sharp & Dohme

Market driver

-Increasing demand for levothyroxine
-For a full, detailed list, view our report

Market challenge

-Side effects leading to lesser patient adherence
-For a full, detailed list, view our report

Market trend

-Rising focus on emerging economies
-For a full, detailed list, view our report

Key questions answered in this report

-What will the market size be in 2021 and what will the growth rate be?
-What are the key market trends?
-What is driving this market?
-What are the challenges to market growth?
-Who are the key vendors in this market space?
-What are the market opportunities and threats faced by the key vendors?
-What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Companies Mentioned in this Report: AbbVie, Pfizer, Merck Sharp & Dohme

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

-Global Neurodegenerative Drugs Market to 2022 - Growth Driven by an Aging Population, the Approval of Novel Immunomodulators and Neuromodulators, and Strong Uptake of Marketed Anti-Inflammatory Treatments
-Bleeding Disorders Treatment Market - Global Forecast to 2021
-Post-Traumatic Stress Disorder (PTSD) Global Clinical Trials Review, H2, 2016
-Global Endocrinology Drugs Market 2016-2020
-PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025